[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MA56444A - MODULATEURS DU RÉCEPTEUR ALPHA DES OESTROGÈNES (ERRalpha) - Google Patents

MODULATEURS DU RÉCEPTEUR ALPHA DES OESTROGÈNES (ERRalpha)

Info

Publication number
MA56444A
MA56444A MA056444A MA56444A MA56444A MA 56444 A MA56444 A MA 56444A MA 056444 A MA056444 A MA 056444A MA 56444 A MA56444 A MA 56444A MA 56444 A MA56444 A MA 56444A
Authority
MA
Morocco
Prior art keywords
erralpha
modulators
receptor alpha
estrogene
estrogene receptor
Prior art date
Application number
MA056444A
Other languages
English (en)
Inventor
Joseph Maria Gerardus Barbara Cals
Eugen Deretey
Johannes Petrus Gerardus Klomp
Jaap Gerardus Henricus Lemmers
Arthur Oubrie
Original Assignee
Lead Pharma Holding Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lead Pharma Holding Bv filed Critical Lead Pharma Holding Bv
Publication of MA56444A publication Critical patent/MA56444A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4365Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/4709Non-condensed quinolines and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/472Non-condensed isoquinolines, e.g. papaverine
    • A61K31/4725Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA056444A 2019-07-04 2020-07-01 MODULATEURS DU RÉCEPTEUR ALPHA DES OESTROGÈNES (ERRalpha) MA56444A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19184515 2019-07-04

Publications (1)

Publication Number Publication Date
MA56444A true MA56444A (fr) 2022-05-11

Family

ID=67180693

Family Applications (1)

Application Number Title Priority Date Filing Date
MA056444A MA56444A (fr) 2019-07-04 2020-07-01 MODULATEURS DU RÉCEPTEUR ALPHA DES OESTROGÈNES (ERRalpha)

Country Status (15)

Country Link
US (1) US20220387401A1 (fr)
EP (1) EP3994138A1 (fr)
JP (1) JP2022538363A (fr)
KR (1) KR20220029719A (fr)
CN (1) CN114341135A (fr)
AR (1) AR119348A1 (fr)
AU (1) AU2020298779A1 (fr)
BR (1) BR112021026687A2 (fr)
CA (1) CA3144891A1 (fr)
CO (1) CO2021017619A2 (fr)
IL (1) IL289510A (fr)
MA (1) MA56444A (fr)
MX (1) MX2022000165A (fr)
WO (1) WO2021001453A1 (fr)
ZA (1) ZA202200591B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240051948A (ko) * 2021-08-03 2024-04-22 베이진 엘티디 피라졸로피리디논 화합물
IL315015A (en) 2022-03-01 2024-10-01 Insilico Medicine Ip Ltd Diacylglycerol kinase (DGK) alpha inhibitors and their uses
WO2023165525A1 (fr) * 2022-03-01 2023-09-07 Insilico Medicine Ip Limited Inhibiteurs de diacylglycérol kinase (dgk) alpha et leurs utilisations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ579417A (en) * 2007-03-07 2012-02-24 Janssen Pharmaceutica Nv Substituted phenoxy aminothiazolones as estrogen related receptor-alpha modulators
EP2129668A1 (fr) * 2007-03-07 2009-12-09 Janssen Pharmaceutica N.V. Phénoxy thiazolidinediones substituées comme modulateurs de récepteur alpha d' strogène
CN104119285B (zh) * 2013-04-28 2016-06-29 中国科学院广州生物医药与健康研究院 用作雌激素相关受体调节剂的化合物及其应用

Also Published As

Publication number Publication date
ZA202200591B (en) 2023-07-26
CA3144891A1 (fr) 2021-01-07
BR112021026687A2 (pt) 2022-03-08
IL289510A (en) 2022-03-01
JP2022538363A (ja) 2022-09-01
WO2021001453A1 (fr) 2021-01-07
US20220387401A1 (en) 2022-12-08
AR119348A1 (es) 2021-12-09
CN114341135A (zh) 2022-04-12
KR20220029719A (ko) 2022-03-08
MX2022000165A (es) 2022-05-20
AU2020298779A1 (en) 2022-02-17
EP3994138A1 (fr) 2022-05-11
CO2021017619A2 (es) 2022-04-19

Similar Documents

Publication Publication Date Title
DK3953327T3 (da) Melanocortin-4-receptor-agonister
MA43382A (fr) Modulateurs des récepteurs des chimiokines
DK3490565T3 (da) Azetidinderivater som chemokinreceptormodulatorer og anvendelser deraf
DK3743406T3 (da) Tmem16a modulatorer
DK3743418T3 (da) Chemokinreceptormodulatorer og anvendelser deraf
DK3490986T3 (da) Piperidin-cxcr7-receptormodulatorer
DK4028669T3 (da) Ophængningsindretning
DE112020001082A5 (de) Löschvorrichtung
MA52555A (fr) Modulateurs du récepteur des oestrogènes
DK3749669T3 (da) Ahr-modulatorer
MA56444A (fr) MODULATEURS DU RÉCEPTEUR ALPHA DES OESTROGÈNES (ERRalpha)
DK3763882T3 (da) Hurtigskifteranordning
DK4041653T3 (da) Isolerende anordning
DK3767254T3 (da) Kombinationsvejeindretning
DK4061344T3 (da) 6-hydroxycannabidiol til anvendelse som lægemiddel
DK3581572T3 (da) Adenosin-A3-receptormodulatorer
DK3792604T3 (da) Kombinationsvejeindretning
DE112020000648A5 (de) Bremseinrichtung
ES1257169Y (es) Aparato de alineación
ES1238509Y (es) Aparato bazuqueador
MA56451A (fr) Modulateurs du récepteur nmda
ES1251004Y (es) Dispositivo de proyeccion de contenidos
ES1256693Y (es) Dispositivo antiposada
JP1654182S (ja) ホワイトボード用スタンド
UA42368S (uk) Дисплейний пристрій